Neuroprotective actions of estradiol and novel estrogen analogs in ischemia: Translational implications

Frontiers in Neuroendocrinology

Volumn 32, Issue 3, 2011, Pages 336-352

  Etgen, Anne M ^a   Jover Mengual, Teresa ^b   Suzanne Zukin, R ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Apoptosis; CREB; Estradiol; Estrogen receptor; Global ischemia; GPR30; Hippocampus; Insulin like growth factor 1; Neuroprotection; Stroke

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTRADIOL; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G 1; G PROTEIN COUPLED RECEPTOR 30; GLYCOGEN SYNTHASE KINASE 3BETA; HORMONE RECEPTOR STIMULATING AGENT; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLACEBO; PROTEIN BCL 2; PROTEIN KINASE B; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; STX; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG; WAY 200070 3;

BRAIN ISCHEMIA; COGNITIVE DEFECT; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG RECEPTOR BINDING; DRUG RESPONSE; DRUG SELECTIVITY; HIPPOCAMPAL CA1 REGION; HUMAN; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; REVIEW; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; TRANSIENT ISCHEMIC ATTACK;

EID: 79960557155     PISSN: 00913022     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.yfrne.2010.12.005     Document Type: Review

References (214)

1. Adams M.M., Morrison J.H. Estrogen and the aging hippocampal synapse. Cereb. Cortex 2003, 13:1271-1275.
2. Adams M.M., Fink S.E., Janssen W.G., Shah R.A., Morrison J.H. Estrogen modulates synaptic N-methyl-d-aspartate receptor subunit distribution in the aged hippocampus. J. Comp. Neurol. 2004, 474:419-426.
3. Alkayed N.J., Murphy S.J., Traystman R.J., Hurn P.D., Miller V.M. Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke 2000, 31:161-168.
4. Alonso de Lecinana M., Egido J.A. Estrogens as neuroprotectants against ischemic stroke. Cerebrovasc. Dis. 2006, 21(Suppl. 2):48-53.
5. Amantea D., Russo R., Bagetta G., Corasaniti M.T. From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol. Res. 2005, 52:119-132.
6. M.A. Arevalo, M. Santos-Galindo, M.J. Bellini, I. Azcoitia, L.M. Garcia-Segura, Actions of estrogens on glial cells: implications for neuroprotection, Biochim. Biophys. Acta (2009).
7. Arnold S., Beyer C. Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target. J. Neurochem. 2009, 110:1-11.
8. Bae S., Zhang L. Gender differences in cardioprotection against ischemia/reperfusion injury in adult rat hearts: focus on Akt and protein kinase C signaling. J. Pharmacol. Exp. Therap. 2005, 315:1125-1135.
9. Bairey Merz C.N., Johnson B.D., Sharaf B.L., Bittner V., Berga S.L., Braunstein G.D., Hodgson T.K., Matthews K.A., Pepine C.J., Reis S.E., Reichek N., Rogers W.J., Pohost G.M., Kelsey S.F., Sopko G. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J. Am. Coll. Cardiol. 2003, 41:413-419.
10. Barnes C.A., Rao G., Houston F.P. LTP induction threshold change in old rats at the perforant path-granule cell synapse. Neurobiol. Aging 2000, 21:613-620.
11. Barnes C.A., Rao G., Orr G. Age-related decrease in the Schaffer collateral-evoked EPSP in awake, freely behaving rats. Neural. Plast. 2000, 7:167-178.
12. Barron A.M., Fuller S.J., Verdile G., Martins R.N. Reproductive hormones modulate oxidative stress in Alzheimer's disease. Antioxid. Redox Signal 2006, 8:2047-2059.
13. Bjornstrom L., Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol. Endocrinol. 2005, 19:833-842.
14. Blasko E., Haskell C.A., Leung S., Gualtieri G., Halks-Miller M., Mahmoudi M., Dennis M.K., Prossnitz E.R., Karpus W.J., Horuk R. Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis. J. Neuroimmunol. 2009, 214:67-77.
15. Bologa C.G., Revankar C.M., Young S.M., Edwards B.S., Arterburn J.B., Kiselyov A.S., Parker M.A., Tkachenko S.E., Savchuck N.P., Sklar L.A., Oprea T.I., Prossnitz E.R. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat. Chem. Biol. 2006, 2:207-212.
16. Bondanelli M., Ambrosio M.R., Onofri A., Bergonzoni A., Lavezzi S., Zatelli M.C., Valle D., Basaglia N., Degli Uberti E.C. Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome. J. Clin. Endocrinol. Metab. 2006, 91:3928-3934.
17. Booth E.A., Lucchesi B.R. Estrogen-mediated protection in myocardial ischemia-reperfusion injury. Cardiovasc. Toxicol. 2008, 8:101-113.
18. Bourque M., Dluzen D.E., Di Paolo T. Neuroprotective actions of sex steroids in Parkinson's disease. Front. Neuroendocrinol. 2009, 30:142-157.
19. Brann D.W., Dhandapani K., Wakade C., Mahesh V.B., Khan M.M. Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids 2007, 72:381-405.
20. Brown C.M., Suzuki S., Jelks K.A., Wise P.M. Estradiol is a potent protective. Semin. Reprod. Med. 2009, 27:240-249.
21. Bryant D.N., Sheldahl L.C., Marriott L.K., Shapiro R.A., Dorsa D.M. Multiple pathways transmit neuroprotective effects of gonadal steroids. Endocrine 2006, 29:199-207.
22. Burguete M.C., Torregrosa G., Perez-Asensio F.J., Castello-Ruiz M., Salom J.B., Gil J.V., Alborch E. Dietary phytoestrogens improve stroke outcome after transient focal cerebral ischemia in rats. Eur. J. Neurosci. 2006, 23:703-710.
23. Burke S.N., Barnes C.A. Senescent synapses and hippocampal circuit dynamics. Trends Neurosci. 2010, 33:153-161.
24. Calderone A., Jover T., Noh K.M., Tanaka H., Yokota H., Lin Y., Grooms S.Y., Regis R., Bennett M.V., Zukin R.S. Ischemic insults derepress the gene silencer REST in neurons destined to die. J. Neurosci. 2003, 23:2112-2121.
25. Canese R., Fortuna S., Lorenzini P., Podo F., Michalek H. Transient global brain ischemia in young and aged rats: differences in severity and progression, but not localisation, of lesions evaluated by magnetic resonance imaging. Magma 1998, 7:28-34.
26. Cardona-Gomez P., Perez M., Avila J., Garcia-Segura L.M., Wandosell F. Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus. Mol. Cell. Neurosci. 2004, 25:363-373.
27. Cardona-Gomez G.P., Arango-Davila C., Gallego-Gomez J.C., Barrera-Ocampo A., Pimienta H., Garcia-Segura L.M. Estrogen dissociates Tau and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor subunit in postischemic hippocampus. Neuroreport 2006, 17:1337-1341.
28. Carswell H.V., Macrae I.M., Gallagher L., Harrop E., Horsburgh K.J. Neuroprotection by a selective estrogen receptor beta agonist in a mouse model of global ischemia. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H1501-H1504.
29. Chambliss K.L., Wu Q., Oltmann S., Konaniah E.S., Umetani M., Korach K.S., Thomas G.D., Mineo C., Yuhanna I.S., Kim S.H., Madak-Erdogan Z., Maggi A., Dineen S.P., Roland C.L., Hui D.Y., Brekken R.A., Katzenellenbogen J.A., Katzenellenbogen B.S., Shaul P.W. Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J. Clin. Invest. 2010, 120:2319-2330.
30. Chen J., Adachi N., Liu K., Arai T. The effects of 17beta-estradiol on ischemia-induced neuronal damage in the gerbil hippocampus. Neuroscience 1998, 87:817-822.
31. Dai X., Chen L., Sokabe M. Neurosteroid estradiol rescues ischemia-induced deficit in the long-term potentiation of rat hippocampal CA1 neurons. Neuropharmacology 2007, 52:1124-1138.
32. Daniel J.M., Bohacek J. The critical period hypothesis of estrogen effects on cognition: Insights from basic research. Biochim Biophys Acta 2010, 1800:1068-1076.
33. Daniel J.M., Hulst J.L., Berbling J.L. Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period of ovarian hormone deprivation. Endocrinology 2006, 147:607-614.
34. Davis M., Mendelow A.D., Perry R.H., Chambers I.R., James O.F. Experimental stroke and neuroprotection in the aging rat brain. Stroke 1995, 26:1072-1078.
35. De Butte-Smith M., Nguyen A.P., Zukin R.S., Etgen A.M., Colbourne F. Failure of estradiol to ameliorate global ischemia-induced CA1 sector injury in middle-aged female gerbils. Brain Res. 2007, 1153:214-220.
36. De Butte-Smith M., Gulinello M., Zukin R.S., Etgen A.M. Chronic estradiol treatment increases CA1 cell survival but does not improve visual or spatial recognition memory after global ischemia in middle-aged female rats. Horm. Behav. 2009, 55:442-453.
37. de Lecinana M.A., Egido J.A., Fernandez C., Martinez-Vila E., Santos S., Morales A., Martinez E., Pareja A., Alvarez-Sabin J., Casado I. Risk of ischemic stroke and lifetime estrogen exposure. Neurology 2007, 68:33-38.
38. Denti L., Annoni V., Cattadori E., Salvagnini M.A., Visioli S., Merli M.F., Corradi F., Ceresini G., Valenti G., Hoffman A.R., Ceda G.P. Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. Am. J. Med. 2004, 117:312-317.
39. Deschamps A.M., Murphy E. Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H1806-H1813.
40. Dietz S.C., Carroll J.S. Interrogating the genome to understand oestrogen-receptor-mediated transcription. Expert Rev. Mol. Med. 2008, 10:e10.
41. Ding Q., Gros R., Limbird L.E., Chorazyczewski J., Feldman R.D. Estradiol-mediated ERK phosphorylation and apoptosis in vascular smooth muscle cells requires GPR 30. Am. J. Physiol. Cell Physiol. 2009, 297:C1178-C1187.
42. Dröge W., Schipper H.M. Oxidative stress and aberrant signaling in aging and cognitive decline. Age. Cell 2007, 6:361-370.
43. Dubal D.B., Zhu H., Yu J., Rau S.W., Shughrue P.J., Merchenthaler I., Kindy M.S., Wise P.M. Estrogen receptor alpha. Not beta, is a critical link in estradiol-mediated protection against brain injury. Proc. Natl. Acad. Sci. USA 2001, 98:1952-1957.
44. Dubal D.B., Rau S.W., Shughrue P.J., Zhu H., Yu J., Cashion A.B., Suzuki S., Gerhold L.M., Bottner M.B., Dubal S.B., Merchanthaler I., Kindy M.S., Wise P.M. Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERalpha in estradiol-mediated protection against delayed cell death. Endocrinology 2006, 147:3076-3084.
45. Dumas J., Hancur-Bucci C., Naylor M., Sites C., Newhouse P. Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis. Horm. Behav. 2008, 53:159-169.
46. Eisinger-Mathason T.S.K., Andrade J., Lannigan D.A. RSK in tumorigenesis: connections to steroid signaling. Steroids 2010, 75:191-202.
47. Elzer J.G., Muhammad S., Wintermantel T.M., Regnier-Vigouroux A., Ludwig J., Schutz G., Schwaninger M. Neuronal estrogen receptor-alpha mediates neuroprotection by 17beta-estradiol. J. Cereb. Blood Flow Metab. 2010, 30:935-942.
48. Espeland M.A., Rapp S.R., Shumaker S.A., Brunner R., Manson J.E., Sherwin B.B., Hsia J., Margolis K.L., Hogan P.E., Wallace R., Dailey M., Freeman R., Hays J. Conjugated equine estrogens and global cognitive function in postmenopausal women: women's health initiative memory study. Jama 2004, 291:2959-2968.
49. A.M. Etgen, M. Acosta-Martinez, Participation of growth factor signal transduction pathways in estradiol facilitation of female reproductive behavior. Endocrinology (2003) en.2003-0157.
50. Farr T.D., Carswell H.V., Gsell W., Macrae I.M. Estrogen receptor beta agonist diarylpropiolnitrile (DPN) does not mediate neuroprotection in a rat model of permanent focal ischemia. Brain Res. 2007, 1185:275-282.
51. Feldman R.D., Gros R. Rapid vascular effects of steroids - a question of balance?. Can. J. Cardiol. 2010, 26(1):22-26.
52. Fernandez S.M., Frick K.M. Chronic oral estrogen affects memory and neurochemistry in middle-aged female mice. Behav. Neurosci. 2004, 118:1340-1351.
53. Filardo E.J. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer. J. Steroid Biochem. Mol. Biol. 2002, 80:231-238.
54. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol. 2000, 14:1649-1660.
55. Filardo E.J., Quinn J.A., Frackelton A.R. And K.I. Bland, Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol. Endocrinol. 2002, 16:70-84.
56. Filardo E., Quinn J., Pang Y., Graeber C., Shaw S., Dong J., Thomas P. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 2007, 148:3236-3245.
57. Filardo E.J., Quinn J.A., Sabo E. Association of the membrane estrogen receptor, GPR30, with breast tumor metastasis and transactivation of the epidermal growth factor receptor. Steroids 2008, 73:870-873.
58. Fitzpatrick J.L., Mize A.L., Wade C.B., Harris J.A., Shapiro R.A., Dorsa D.M. Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expression of estrogen receptor alpha or beta and activation of the MAPK pathway. J. Neurochem. 2002, 82:674-682.
59. Formisano L., Noh K.M., Miyawaki T., Mashiko T., Bennett M.V., Zukin R.S. Ischemic insults promote epigenetic reprogramming of mu opioid receptor expression in hippocampal neurons. Proc. Natl. Acad. Sci. USA 2007, 104:4170-4175.
60. Freeman W.M., Vanguilder H.D., Bennett C., Sonntag W.E. Cognitive performance and age-related changes in the hippocampal proteome. Neuroscience 2009, 159:183-195.
61. Frick K.M. Estrogens and age-related memory decline in rodents: what have we learned and where do we go from here?. Horm. Behav. 2009, 55:2-23.
62. Fuh J.L., Wang S.J., Lu S.R., Juang K.D., Lee S.J. Alterations in cognitive function during the menopausal transition. J. Am. Geriatr. Soc. 2003, 51:431-432.
63. Fuh J.L., Wang S.J., Lee S.J., Lu S.R., Juang K.D. A longitudinal study of cognition change during early menopausal transition in a rural community. Maturitas 2006, 53:447-453.
64. Funahashi T., Floyd R.A., Carney J.M. Age effect on brain pH during ischemia/reperfusion and pH influence on peroxidation. Neurobiol. Aging 1994, 15:161-167.
65. Galea L.A., Uban K.A., Epp J.R., Brummelte S., Barha C.K., Wilson W.L., Lieblich S.E., Pawluski J.L. Endocrine regulation of cognition and neuroplasticity: our pursuit to unveil the complex interaction between hormones, the brain, and behaviour. Can. J. Exp. Psychol. 2008, 62:247-260.
66. Garcia-Segura L.M., Arévalo M.-A., Azcoitia I., Luciano M. Interactions of Estradiol and Insulin-like Growth Factor-I Signalling in the Nervous System: New Advances 2010, Progress in Brain Research, Elsevier, pp. 251-272.
67. Gibbs R.B. Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol. Aging 2000, 21:107-116.
68. Gibbs R.B. Effects of ageing and long-term hormone replacement on cholinergic neurones in the medial septum and nucleus basalis magnocellularis of ovariectomized rats. J. Neuroendocrinol. 2003, 15:477-485.
69. Gibbs R.B., Mauk R., Nelson D., Johnson D.A. Donepezil treatment restores the ability of estradiol to enhance cognitive performance in aged rats: evidence for the cholinergic basis of the critical period hypothesis. Horm. Behav. 2009, 56:73-83.
70. Gibson C.L., Gray L.J., Murphy S.P., Bath P.M. Estrogens and experimental ischemic stroke: a systematic review. J. Cereb. Blood Flow Metab. 2006, 26:1103-1113.
71. Gingerich S., Kim G.L., Chalmers J.A., Koletar M.M., Wang X., Wang Y., Belsham D.D. Estrogen receptor alpha and G-protein coupled receptor 30 mediate the neuroprotective effects of 17[beta]-estradiol in novel murine hippocampal cell models. Neuroscience 2010, 170:54-66.
72. Gould E., Tanapat P., Rydel T., Hastings N. Regulation of hippocampal neurogenesis in adulthood. Biol. Psychiat. 2000, 48:715-720.
73. Grady D., Herrington D., Bittner V., Blumenthal R., Davidson M., Hlatky M., Hsia J., Hulley S., Herd A., Khan S., Newby L.K., Waters D., Vittinghoff E., Wenger N. Cardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II). Jama 2002, 288:49-57.
74. Gu Q., Moss R.L. 17 beta-Estradiol potentiates kainate-induced currents via activation of the cAMP cascade. J. Neurosci. 1996, 16:3620-3629.
75. Gu G., Rojo A.A., Zee M.C., Yu J., Simerly R.B. Hormonal regulation of CREB phosphorylation in the anteroventral periventricular nucleus. J. Neurosci. 1996, 16:3035-3044.
76. Gu Q., Korach K.S., Moss R.L. Rapid action of 17beta-estradiol on kainate-induced currents in hippocampal neurons lacking intracellular estrogen receptors. Endocrinology 1999, 140:660-666.
77. Guan J., Bennet L., Gluckman P.D., Gunn A.J. Insulin-like growth factor-1 and post-ischemic brain injury. Prog. Neurobiol. 2003, 70:443-462.
78. Gulinello M., Lebesgue D., Jover-Mengual T., Zukin R.S., Etgen A.M. Acute and chronic estradiol treatments reduce memory deficits induced by transient global ischemia in female rats. Horm. Behav. 2006, 49:246-260.
79. Hao J., Janssen W.G., Tang Y., Roberts J.A., McKay H., Lasley B., Allen P.B., Greengard P., Rapp P.R., Kordower J.H., Hof P.R., Morrison J.H. Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. J. Comp. Neurol. 2003, 465:540-550.
80. Hastings N.B., Gould E. Rapid extension of axons into the CA3 region by adult-generated granule cells. J. Comp. Neurol. 1999, 413:146-154.
81. Hoffman G.E., Merchenthaler I., Zup S.L. Neuroprotection by ovarian hormones in animal models of neurological disease. Endocrine 2006, 29:217-231.
82. Huang P., Chandra V., Rastinejad F. Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. Ann. Rev. Physiol. 2010, 72:247-272.
83. Hutchens M.P., Nakano T., Kosaka Y., Dunlap J., Zhang W., Herson P.S., Murphy S.J., Anderson S., Hurn P.D. Estrogen is renoprotective via a nonreceptor-dependent mechanism after cardiac arrest in vivo. Anesthesiology 2010, 112:395-405.
84. Jin K., Minami M., Xie L., Sun Y., Mao X.O., Wang Y., Simon R.P., Greenberg D.A. Ischemia-induced neurogenesis is preserved but reduced in the aged rodent brain. Age. Cell 2004, 3:373-377.
85. Jover T., Tanaka H., Calderone A., Oguro K., Bennett M.V., Etgen A.M., Zukin R.S. Estrogen protects against global ischemia-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal CA1. J. Neurosci. 2002, 22:2115-2124.
86. Jover-Mengual T., Zukin R.S., Etgen A.M. MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia. Endocrinology 2007, 148:1131-1143.
87. Jover-Mengual T., Miyawaki T., Latuszek A., Alborch E., Zukin R.S., Etgen A.M. Acute estradiol protects CA1 neurons from ischemia-induced apoptotic cell death via the PI3K/Akt pathway. Brain Res. 2010, 1321:1-12.
88. Jung J.E., Kim G.S., Narasimhan P., Song Y.S., Chan P.H. Regulation of Mn-superoxide dismutase activity and neuroprotection by STAT3 in mice after cerebral ischemia. J. Neurosci. 2009, 29:7003-7014.
89. Juul A., Scheike T., Davidsen M., Gyllenborg J., Jorgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002, 106:939-944.
90. Kadar T., Silbermann M., Steinhagen-Thiessen E., Levy A. Age-related changes in the cholinergic components within the central nervous system of CW1 female mice. I. Structural analysis. Mech. Aging Dev. 1989, 47:133-144.
91. Kadar T., Silbermann M., Weissman B.A., Levy A. Age-related changes in the cholinergic components within the central nervous system. II. Working memory impairment and its relation to hippocampal muscarinic receptors. Mech. Aging Dev. 1990, 55:139-149.
92. Kelly M.J., Levin E.R. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol. Metab. 2001, 12:152-156.
93. Kelly M.J., Ronnekleiv O.K. Membrane-initiated estrogen signaling in hypothalamic neurons. Mol. Cell Endocrinol. 2008, 290:14-23.
94. Kelly M.J., Ronnekleiv O.K. Control of CNS neuronal excitability by estrogens via membrane-initiated signaling. Mol. Cell. Endocrinol. 2009, 308:17-25.
95. Kelly M.J., Lagrange A.H., Wagner E.J., Ronnekleiv O.K. Rapid effects of estrogen to modulate G protein-coupled receptors via activation of protein kinase A and protein kinase C pathways. Steroids 1999, 64:64-75.
96. Kelly M.J., Ronnekleiv O.K., Ibrahim N., Lagrange A.H., Wagner E.J. Estrogen modulation of K(+) channel activity in hypothalamic neurons involved in the control of the reproductive axis. Steroids 2002, 67:447-456.
97. Kelly M.J., Qiu J., Wagner E.J., Ronnekleiv O.K. Rapid effects of estrogen on G protein-coupled receptor activation of potassium channels in the central nervous system (CNS). J. Steroid Biochem. Mol. Biol. 2002, 83:187-193.
98. Kim S.-Y., Weiss J., Tong M., Laronda M.M., Lee E.-J., Jameson J.L. Foxl2, a forkhead transcription factor, modulates nonclassical activity of the estrogen receptor-{alpha}. Endocrinology 2009, 150:5085-5093.
99. Koerner I.P., Zhang W., Cheng J., Parker S., Hurn P.D., Alkayed N.J. Soluble epoxide hydrolase: regulation by estrogen and role in the inflammatory response to cerebral ischemia. Front. Biosci. 2008, 13:2833-2841.
100. Kokaia Z., Lindvall O. Neurogenesis after ischaemic brain insults. Curr. Opin. Neurobiol. 2003, 13:127-132.
101. Kompoliti K., Chu Y., Polish A., Roberts J., McKay H., Mufson E.J., Leurgans S., Morrison J.H., Kordower J.H. Effects of estrogen replacement therapy on cholinergic basal forebrain neurons and cortical cholinergic innervation in young and aged ovariectomized rhesus monkeys. J. Comp. Neurol. 2004, 472:193-207.
102. Kondo Y., Suzuki K., Sakuma Y. Estrogen alleviates cognitive dysfunction following transient brain ischemia in ovariectomized gerbils. Neurosci. Lett. 1997, 238:45-48.
103. Lacreuse A. Effects of ovarian hormones on cognitive function in nonhuman primates. Neuroscience 2006, 138:859-867.
104. Lacreuse A., Wilson M.E., Herndon J.G. Estradiol but not raloxifene, improves aspects of spatial working memory in aged ovariectomized rhesus monkeys. Neurobiol. Aging 2002, 23:589-600.
105. Lagrange A.H., Wagner E.J., Ronnekleiv O.K., Kelly M.J. Estrogen rapidly attenuates a GABAB response in hypothalamic neurons. Neuroendocrinology 1996, 64:114-123.
106. Lebesgue D., Chevaleyre V., Zukin R.S., Etgen A.M. Estradiol rescues neurons from global ischemia-induced cell death: multiple cellular pathways of neuroprotection. Steroids 2009, 74:555-561.
107. Lebesgue D., Traub M., De Butte-Smith M., Chen C., Zukin R.S., Kelly M.J., Etgen A.M. Acute administration of non-classical estrogen receptor agonists attenuates ischemia-induced hippocampal neuron loss in middle-aged female rats. PLoS One 2010, 5:e8642.
108. Liang H.W., Qiu S.F., Shen J., Sun L.N., Wang J.Y., Bruce I.C., Xia Q. Genistein attenuates oxidative stress and neuronal damage following transient global cerebral ischemia in rat hippocampus. Neurosci. Lett. 2008, 438:116-120.
109. Lisabeth L.D., Beiser A.S., Brown D.L., Murabito J.M., Kelly-Hayes M., Wolf P.A. Age at natural menopause and risk of ischemic stroke: the Framingham heart study. Stroke 2009, 40:1044-1049.
110. Liu R., Wang X., Liu Q., Yang S.H., Simpkins J.W. Dose dependence and therapeutic window for the neuroprotective effects of 17beta-estradiol when administered after cerebral ischemia. Neurosci. Lett. 2007, 415:237-241.
111. Lo E.H., Dalkara T., Moskowitz M.A. Mechanisms challenges and opportunities in stroke. Nat. Rev. Neurosci. 2003, 4:399-415.
112. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
113. Lopez-Lopez C., LeRoith D., Torres-Aleman I. Insulin-like growth factor I is required for vessel remodeling in the adult brain. PNAS 2004, 101:9833-9838.
114. Lovekamp-Swan T., Glendenning M., Schreihofer D.A. A high soy diet reduces programmed cell death and enhances bcl-xL expression in experimental stroke. Neuroscience 2007, 148:644-652.
115. Madak-Erdogan Z., Kieser K.J., Kim S.H., Komm B., Katzenellenbogen J.A., Katzenellenbogen B.S. Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Mol. Endocrinol. 2008, 22:2116-2127.
116. Maki P.M. Hormone therapy and cognitive function: is there a critical period for benefit?. Neuroscience 2006, 138:1027-1030.
117. Marin R., Ramirez C., Morales A., Gonzalez M., Alonso R., Diaz M. Modulation of Abeta-induced neurotoxicity by estrogen receptor alpha and other associated proteins in lipid rafts. Steroids 2008, 73:992-996.
118. McEwen B.S. Sex, stress and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol. Aging 2002, 23:921-939.
119. Mendez P., Azcoitia I., Garcia-Segura L.M. Interdependence of oestrogen and insulin-like growth factor-I in the brain: potential for analysing neuroprotective mechanisms. J. Endocrinol. 2005, 185:11-17.
120. Mendez P., Wandosell F., Garcia-Segura L.M. Cross-talk between estrogen receptors and insulin-like growth factor-I receptor in the brain: cellular and molecular mechanisms. Front. Neuroendocrinol. 2006, 27:391-403.
121. Merchenthaler I., Dellovade T.L., Shughrue P.J. Neuroprotection by estrogen in animal models of global and focal ischemia. Ann. NY Acad. Sci. 2003, 1007:89-100.
122. Meyer P.M., Powell L.H., Wilson R.S., Everson-Rose S.A., Kravitz H.M., Luborsky J.L., Madden T., Pandey D., Evans D.A. A population-based longitudinal study of cognitive functioning in the menopausal transition. Neurology 2003, 61:801-806.
123. Miller N.R., Jover T., Cohen H.W., Zukin R.S., Etgen A.M. Estrogen can act via estrogen receptor alpha and beta to protect hippocampal neurons against global ischemia-induced cell death. Endocrinology 2005, 146:3070-3079.
124. Mize A.L., Shapiro R.A., Dorsa D.M. Estrogen receptor-mediated neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway. Endocrinology 2003, 144:306-312.
125. R. Morkuniene, O. Arandarcikaite, L. Ivanoviene, V. Borutaite, Estradiol-induced protection against ischemia-induced heart mitochondrial damage and caspase activation is mediated by protein kinase G, Biochim. Biophys. Acta.
126. Moskowitz M.A., Lo E.H., Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010, 67:181-198.
127. Neal-Perry G.S., Zeevalk G.D., Santoro N.F., Etgen A.M. Attenuation of preoptic area glutamate release correlates with reduced luteinizing hormone secretion in middle-aged female rats. Endocrinology 2005, 146:4331-4339.
128. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E., Pettersson K., Warner M., Gustafsson J.A. Mechanisms of estrogen action. Physiol. Rev. 2001, 81:1535-1565.
129. Noppens R.R., Kofler J., Grafe M.R., Hurn P.D., Traystman R.J. Estradiol after cardiac arrest and cardiopulmonary resuscitation is neuroprotective and mediated through estrogen receptor-beta. J. Cereb. Blood Flow Metab. 2009, 29:277-286.
130. Novotny J.L., Simpson A.M., Tomicek N.J., Lancaster T.S., Korzick D.H. Rapid estrogen receptor-alpha activation improves ischemic tolerance in aged female rats through a novel protein kinase C epsilon-dependent mechanism. Endocrinology 2009, 150:889-896.
131. Pawluski J.L., Brummelte S., Barha C.K., Crozier T.M., Galea L.A. Effects of steroid hormones on neurogenesis in the hippocampus of the adult female rodent during the estrous cycle, pregnancy, lactation and aging. Front. Neuroendocrinol. 2009, 30:343-357.
132. Perez-Martin M., Azcoitia I., Trejo J.L., Sierra A., Garcia-Segura L.M. An antagonist of estrogen receptors blocks the induction of adult neurogenesis by insulin-like growth factor-I in the dentate gyrus of adult female rat. Eur. J. Neurosci. 2003, 18:923-930.
133. Peri A., Danza G., Benvenuti S., Luciani P., Deledda C., Rosati F., Cellai I., Serio M. New insights on the neuroprotective role of sterols and sex steroids: the seladin-1/DHCR24 paradigm. Front. Neuroendocrinol. 2009, 30:119-129.
134. Petito C.K., Feldmann E., Pulsinelli W.A., Plum F. Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology 1987, 37:1281-1286.
135. Pietrzkowski Z., Wernicke D., Porcu P., Jameson B.A., Baserga R. Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1. Cancer Res. 1992, 52:6447-6451.
136. Plamondon H., Morin A., Charron C. Chronic 17beta-estradiol pretreatment and ischemia-induced hippocampal degeneration and memory impairments: a 6-month survival study. Horm. Behav. 2006, 50:361-369.
137. Prossnitz E.R., Arterburn J.B., Sklar L.A. GPR30: a G protein-coupled receptor for estrogen. Mol. Cell. Endocrinol. 2007, 265-266:138-142.
138. Prossnitz E.R., Arterburn J.B., Smith H.O., Oprea T.I., Sklar L.A., Hathaway H.J. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu. Rev. Physiol. 2008, 70:165-190.
139. Prossnitz E.R., Oprea T.I., Sklar L.A., Arterburn J.B. The ins and outs of GPR30: a transmembrane estrogen receptor. J. Steroid Biochem. Mol. Biol. 2008, 109:350-353.
140. Prossnitz E.R., Sklar L.A., Oprea T.I., Arterburn J.B. GPR30: a novel therapeutic target in estrogen-related disease. Trends Pharmacol. Sci. 2008, 29:116-123.
141. Pulsinelli W.A., Brierley J.B. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 1979, 10:267-272.
142. Pulsinelli W.A., Brierley J.B., Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 1982, 11:491-498.
143. Qiu J., Bosch M.A., Tobias S.C., Grandy D.K., Scanlan T.S., Ronnekleiv O.K., Kelly M.J. Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. J. Neurosci. 2003, 23:9529-9540.
144. Qiu J., Ronnekleiv O.K., Kelly M.J. Modulation of hypothalamic neuronal activity through a novel G-protein-coupled estrogen membrane receptor. Steroids 2008, 73:985-991.
145. Quesada A., Etgen A.M. Functional interactions between estrogen and insulin-like growth factor-I in the regulation of alpha 1B-adrenoceptors and female reproductive function. J. Neurosci. 2002, 22:2401-2408.
146. Quesada A., Micevych P.E. Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions. J. Neurosci. Res. 2004, 75:107-116.
147. Rapp S.R., Espeland M.A., Shumaker S.A., Henderson V.W., Brunner R.L., Manson J.E., Gass M.L.S., Stefanick M.L., Lane D.S., Hays J., Johnson K.C., Coker L.H., Dailey M., Bowen D. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the women's health initiative memory study: a randomized controlled trial. Jama 2003, 289:2663-2672.
148. Raval A.P., Saul I., Dave K.R., DeFazio R.A., Perez-Pinzon M.A., Bramlett H. Pretreatment with a single estradiol-17beta bolus activates cyclic-AMP response element binding protein and protects CA1 neurons against global cerebral ischemia. Neuroscience 2009, 160:307-318.
149. Raz L., Khan M.M., Mahesh V.B., Vadlamudi R.K., Brann D.W. Rapid estrogen signaling in the brain. Neurosignals 2008, 16:140-153.
150. Ronnekleiv O.K., Kelly M.J. Diversity of ovarian steroid signaling in the hypothalamus. Front. Neuroendocrinol. 2005, 26:65-84.
151. Ronnekleiv O.K., Malyala A., Kelly M.J. Membrane-initiated signaling of estrogen in the brain. Semin. Reprod. Med. 2007, 25:165-177.
152. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M., Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Jama 2002, 288:321-333.
153. Rossouw J.E., Prentice R.L., Manson J.E., Wu L., Barad D., Barnabei V.M., Ko M., LaCroix A.Z., Margolis K.L., Stefanick M.L. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. Jama 2007, 297:1465-1477.
154. Safe S., Kim K. Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J. Mol. Endocrinol. 2008, 41:263-275.
155. Samani A.A., Yakar S., LeRoith D., Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr. Rev. 2007, 28:20-47.
156. Sandstrom N.J., Rowan M.H. Acute pretreatment with estradiol protects against CA1 cell loss and spatial learning impairments resulting from transient global ischemia. Horm. Behav. 2007, 51:335-345.
157. Saravia F., Revsin Y., Lux-Lantos V., Beauquis J., Homo-Delarche F., De Nicola A.F. Oestradiol restores cell proliferation in dentate gyrus and subventricular zone of streptozotocin-diabetic mice. J. Neuroendocrinol. 2004, 16:704-710.
158. Saravia F.E., Beauquis J., Revsin Y., Homo-Delarche F., De Kloet E.R., De Nicola A.F. Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment. Cell Mol. Neurobiol. 2006, 26:943-957.
159. Selvamani A., Sohrabji F. Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats. Neurobiol. Aging 2010, 31:1618-1628.
160. Selvamani A., Sohrabji F. The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with age-dependent loss of insulin-like growth factor-1. J. Neurosci. 2010, 30:6852-6861.
161. Shen B., Vetri F., Mao L., Xu H.L., Paisansathan C., Pelligrino D.A. Aldose reductase inhibition ameliorates the detrimental effect of estrogen replacement therapy on neuropathology in diabetic rats subjected to transient forebrain ischemia. Brain Res. 2010, 1342:118-126.
162. Sherwin B.B. Estrogen and memory in women: how can we reconcile the findings?. Horm. Behav. 2005, 47:371-375.
163. Sherwin B.B. Estrogen and cognitive aging in women. Neuroscience 2006, 138:1021-1026.
164. Sherwin B.B. The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature?. J. Neuroendocrinol. 2007, 19:77-81.
165. Sherwin B.B. Estrogen therapy: is time of initiation critical for neuroprotection?. Nat. Rev. Endocrinol. 2009, 5:620-627.
166. Sherwin B.B., Henry J.F. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front. Neuroendocrinol. 2008, 29:88-113.
167. Shioda N., Han F., Fukunaga K., Bagetta G.C.M.T.S.T.a.S.S. Chapter 26 Role of Akt and Erk Signaling in the Neurogenesis Following Brain Ischemia 2009, International Review of Neurobiology, Academic Press, pp. 375-387.
168. Simpkins J.W., Singh M. More than a decade of estrogen neuroprotection. Alzheimers Dement. 2008, 4:S131-S136.
169. Simpkins J.W., Yang S.H., Liu R., Perez E., Cai Z.Y., Covey D.F., Green P.S. Estrogen-like compounds for ischemic neuroprotection. Stroke 2004, 35:2648-2651.
170. Simpkins J.W., Wen Y., Perez E., Yang S., Wang X. Role of nonfeminizing estrogens in brain protection from cerebral ischemia: an animal model of Alzheimer's disease neuropathology. Ann. NY Acad. Sci. 2005, 1052:233-242.
171. Simpkins J.W., Yang S.H., Sarkar S.N., Pearce V. Estrogen actions on mitochondria-physiological and pathological implications. Mol. Cell. Endocrinol. 2008, 290:51-59.
172. Stapels M., Piper C., Yang T., Li M., Stowell C., Xiong Z.G., Saugstad J., Simon R.P., Geromanos S., Langridge J., Lan J.Q., Zhou A. Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance. Sci. Signal 2010, 3:ra15.
173. Stice J.P., Lee J.S., Pechenino A.S., Knowlton A.A. Estrogen aging and the cardiovascular system. Future Cardiol. 2009, 5:93-103.
174. Strom J.O., Theodorsson A., Theodorsson E. Dose-related neuroprotective versus neurodamaging effects of estrogens in rat cerebral ischemia: a systematic analysis. J. Cereb. Blood Flow Metab. 2009, 29:1359-1372.
175. Sudo S., Wen T.C., Desaki J., Matsuda S., Tanaka J., Arai T., Maeda N., Sakanaka M. Beta-estradiol protects hippocampal CA1 neurons against transient forebrain ischemia in gerbil. Neurosci. Res. 1997, 29:345-354.
176. Sutherland G.R., Dix G.A., Auer R.N. Effect of age in rodent models of focal and forebrain ischemia. Stroke 1996, 27:1663-1667. (discussion 1668).
177. Sutton-Tyrrell K., Wildman R.P., Matthews K.A., Chae C., Lasley B.L., Brockwell S., Pasternak R.C., Lloyd-Jones D., Sowers M.F., Torrens J.I. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 2005, 111:1242-1249.
178. Suzuki S., Brown C.M., Dela Cruz C.D., Yang E., Bridwell D.A., Wise P.M. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc. Natl. Acad. Sci. USA 2007, 104:6013-6018.
179. Suzuki S., Brown C.M., Wise P.M. Neuroprotective effects of estrogens following ischemic stroke. Front. Neuroendocrinol. 2009, 30:201-211.
180. Thomas P., Dong J. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J. Steroid Biochem. Mol. Biol. 2006, 102:175-179.
181. Thomas P., Pang Y., Filardo E.J., Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005, 146:624-632.
182. Todd B.J., Fraley G.S., Peck A.C., Schwartz G.J., Etgen A.M. Central insulin-like growth factor 1 receptors play distinct roles in the control of reproduction, food intake, and body weight in female rats. Biol. Reprod. 2007, 77:492-503.
183. Todd B.J., Merhi Z.O., Shu J., Etgen A.M., Neal-Perry G.S. Hypothalamic insulin-like growth factor-I receptors are necessary for hormone-dependent luteinizing hormone surges: implications for female reproductive aging. Endocrinology 2010, 151:1356-1366.
184. Toran-Allerand C.D., Miranda R.C., Bentham W.D., Sohrabji F., Brown T.J., Hochberg R.B., MacLusky N.J. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc. Natl. Acad. Sci. USA 1992, 89:4668-4672.
185. Towart L.A., Alves S.E., Znamensky V., Hayashi S., McEwen B.S., Milner T.A. Subcellular relationships between cholinergic terminals and estrogen receptor-alpha in the dorsal hippocampus. J. Comp. Neurol. 2003, 463:390-401.
186. Traub M.L., De Butte-Smith M., Zukin R.S., Etgen A.M. Oestradiol and insulin-like growth factor-1 reduce cell loss after global ischaemia in middle-aged female rats. J. Neuroendocrinol. 2009, 21:1038-1044.
187. VanGuilder H.D., Yan H., Farley J.A., Sonntag W.E., Freeman W.M. Aging alters the expression of neurotransmission-regulating proteins in the hippocampal synaptoproteome. J. Neurochem. 2010, 113:1577-1588.
188. Varea O., Arevalo M.-A., Garrido J.J., Garcia-Segura L.M., Wandosell F., Mendez P. Interaction of estrogen receptors with insulin-like growth factor-I and Wnt signaling in the nervous system. Steroids 2010, 75:565-569.
189. Viscoli C.M., Brass L.M., Kernan W.N., Sarrel P.M., Suissa S., Horwitz R.I. A clinical trial of estrogen-replacement therapy after ischemic stroke. New Engl. J. Med. 2001, 345:1243-1249.
190. Wade C.B., Robinson S., Shapiro R.A., Dorsa D.M. Estrogen receptor (ER) alpha and ER beta exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway. Endocrinology 2001, 142:2336-2342.
191. Wakade C., Khan M.M., De Sevilla L.M., Zhang Q.G., Mahesh V.B., Brann D.W. Tamoxifen neuroprotection in cerebral ischemia involves attenuation of kinase activation and superoxide production and potentiation of mitochondrial superoxide dismutase. Endocrinology 2008, 149:367-379.
192. Wang Q., Santizo R., Baughman V.L., Pelligrino D.A., Iadecola C. Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats. Stroke 1999, 30:630-637.
193. Wappler E.A., Felszeghy K., Szilagyi G., Gal A., Skopal J., Mehra R.D., Nyakas C., Nagy Z. Neuroprotective effects of estrogen treatment on ischemia-induced behavioural deficits in ovariectomized gerbils at different ages. Behav. Brain Res. 2010, 209:42-48.
194. Weiss G., Skurnick J.H., Goldsmith L.T., Santoro N.F., Park S.J. Menopause and hypothalamic-pituitary sensitivity to estrogen. Jama 2004, 292:2991-2996.
195. Welboren W.-J., Sweep F.C.G.J., Span P.N., Stunnenberg H.G. Genomic actions of estrogen receptor {alpha}: what are the targets and how are they regulated?. Endocr. Relat. Cancer 2009, 16:1073-1089.
196. Wise P.M., Dubal D.B. Estradiol protects against ischemic brain injury in middle-aged rats. Biol. Reprod. 2000, 63:982-985.
197. Wise P.M., Dubal D.B., Wilson M.E., Rau S.W., Bottner M., Rosewell K.L. Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies. Brain Res. Brain Res. Rev. 2001, 37:313-319.
198. Wong M., Moss R.L. Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CA1 neurons. J. Neurosci. 1992, 12:3217-3225.
199. Wong W.P.S., Tiano J.P., Liu S., Hewitt S.C., Le May C., Dalle S.p., Katzenellenbogen J.A., Katzenellenbogen B.S., Korach K.S., Mauvais-Jarvis F. Extranuclear estrogen receptor-α stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis. Proc. Natl. Acad. Sci. 2010, 107:13057-13062.
200. Woods N.F., Smith-Dijulio K., Percival D.B., Tao E.Y., Taylor H.J., Mitchell E.S. Symptoms during the menopausal transition and early postmenopause and their relation to endocrine levels over time: observations from the Seattle Midlife Women's Health Study. J. Womens Health (Larchmt) 2007, 16:667-677.
201. Woolley C.S., Weiland N.G., McEwen B.S., Schwartzkroin P.A. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J. Neurosci. 1997, 17:1848-1859.
202. Xu Y., Armstrong S.J., Arenas I.A., Pehowich D.J., Davidge S.T. Cardioprotection by chronic estrogen or superoxide dismutase mimetic treatment in the aged female rat. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H165-H171.
203. Yamashima T., Tonchev A.B., Borlongan C.V. Differential response to ischemia in adjacent hippocampalsectors: neuronal death in CA1 versus neurogenesis in dentate gyrus. Biotechnol. J. 2007, 2:596-607.
204. Yang L.C., Zhang Q.G., Zhou C.F., Yang F., Zhang Y.D., Wang R.M., Brann D.W. Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus. PLoS One 2010, 5:e9851.
205. Yao H., Sadoshima S., Ooboshi H., Sato Y., Uchimura H., Fujishima M. Age-related vulnerability to cerebral ischemia in spontaneously hypertensive rats. Stroke 1991, 22:1414-1418.
206. Yildirim M., Janssen W.G., Tabori N.E., Adams M.M., Yuen G.S., Akama K.T., McEwen B.S., Milner T.A., Morrison J.H. Estrogen and aging affect synaptic distribution of phosphorylated LIM kinase (pLIMK) in CA1 region of female rat hippocampus. Neuroscience 2008, 152:360-370.
207. Zhang L., Nair A., Krady K., Corpe C., Bonneau R.H., Simpson I.A., Vannucci S.J. Estrogen stimulates microglia and brain recovery from hypoxia-ischemia in normoglycemic but not diabetic female mice. J. Clin. Invest. 2004, 113:85-95.
208. Zhang Q.G., Wang R., Khan M., Mahesh V., Brann D.W. Role of Dickkopf-1, an antagonist of the Wnt/beta-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation. J. Neurosci. 2008, 28:8430-8441.
209. Zhang Q.G., Raz L., Wang R., Han D., De Sevilla L., Yang F., Vadlamudi R.K., Brann D.W. Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation. J. Neurosci. 2009, 29:13823-13836.
210. Zhang W., Iliff J.J., Campbell C.J., Wang R.K., Hurn P.D., Alkayed N.J. Role of soluble epoxide hydrolase in the sex-specific vascular response to cerebral ischemia. J. Cereb. Blood Flow Metab. 2009, 29:1475-1481.
211. Zhao L., Brinton R.D. Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons. Brain Res. 2007, 1172:48-59.
212. Zhao L., Wu T.W., Brinton R.D. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res. 2004, 1010:22-34.
213. Zukin R.S. Eradicating the mediators of neuronal death with a fine-tooth comb. Sci. Signal 2010, 3:pe20.
214. Zukin R.S., Jover T., Yokota H., Calderone A., Simionescu M., Lau C.G. Molecular and cellular mechanisms of ischemia. Stroke Pathophysiology Diagnosis and Management 2004, 29-54. Churchill Livingstone, New York. J.P. Mohr, D.W. Choi, J.C. Grotta, B. Weir, P.A. Wolf (Eds.).